Mahesh Lachyankar is a distinguished Senior Consultant at Independent, where he leverages his extensive expertise in global business development to advance flexible and innovative drug discovery and development initiatives. With a robust background in forging strategic alliances among global pharmaceutical companies, academia, biotech firms, and...
Mahesh Lachyankar is a distinguished Senior Consultant at Independent, where he leverages his extensive expertise in global business development to advance flexible and innovative drug discovery and development initiatives. With a robust background in forging strategic alliances among global pharmaceutical companies, academia, biotech firms, and government agencies, Mahesh has positioned himself as a pivotal figure in the life sciences sector. His proficiency spans multiple therapeutic areas, including ophthalmology, neuroscience, oncology, autoimmune diseases, and metabolic disorders, making him an invaluable asset to organizations seeking to navigate the complexities of drug development.
In his current role, Mahesh provides tailored innovation and consultancy services to a diverse clientele, including pharmaceutical giants, biotech startups, incubator companies, and academic institutions across the USA, Canada, Europe, and Asia. He excels in developing comprehensive business plans and organizational strategies that foster the establishment of efficient hybrid drug discovery groups. His expertise in externalization of research activities and strategic sourcing enables clients to optimize their resources and enhance their research capabilities through effective third-party outsourcing management.
Mahesh's critical evaluation of projects and pipelines ensures that his clients remain competitive in a rapidly evolving market. His skill set encompasses biotechnology, immunology, high-throughput screening, microbiology, stem cells, in vivo studies, portfolio management, clinical research, and the development of large molecules. By integrating these skills into his consultancy approach, Mahesh not only drives innovation but also empowers organizations to achieve their strategic goals in drug development, ultimately contributing to the advancement of healthcare solutions worldwide.
